A detailed history of Investors Research Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Investors Research Corp holds 94 shares of EW stock, worth $6,898. This represents 0.0% of its overall portfolio holdings.

Number of Shares
94
Previous 94 -0.0%
Holding current value
$6,898
Previous $8,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$82.37 - $107.29 $2,388 - $3,111
29 Added 44.62%
94 $8,000
Q2 2022

Jul 21, 2022

BUY
$86.5 - $128.27 $2,681 - $3,976
31 Added 91.18%
65 $6,000
Q1 2022

Apr 13, 2022

BUY
$101.96 - $128.34 $3,466 - $4,363
34 New
34 $4,000
Q3 2021

Oct 27, 2021

SELL
$102.91 - $122.75 $15,745 - $18,780
-153 Closed
0 $0
Q2 2020

Jul 21, 2020

BUY
$57.54 - $76.95 $5,869 - $7,848
102 Added 200.0%
153 $11,000
Q3 2019

Oct 22, 2019

BUY
$61.55 - $75.43 $3,139 - $3,846
51 New
51 $11,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.4B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Investors Research Corp Portfolio

Follow Investors Research Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investors Research Corp, based on Form 13F filings with the SEC.

News

Stay updated on Investors Research Corp with notifications on news.